Add to Basket
Order hotline:
![]() |
+1 404 474 4654 |
![]() |
+1 888 205 9894 (TF) |
Eph Receptor tyrosine Kinase A2 (EPHA2) antibody
| Antigen | Eph Receptor tyrosine Kinase A2 (EPHA2) |
| Clonality | Monoclonal (Kalpha-5H5) |
| Host |
Mouse |
| Reactivity |
Human |
| Application |
Flow Cytometry (FACS), Cell-ELISA (cELISA), Immunofluorescence (IF)
|
![]() |
4 references available |
| Catalog no. | ABIN179724 |
| Quantity | 100 ug (2 mg/ml) |
| Price | 594.29 $ Plus shipping costs $35.00 |
| Shipping to |
|
| Availability | Ships within 3 to 5 Business Days |
Additional Information
| Alternative name | Eph receptor tyrosine kinase A2 (EphA2) |
| Immunogen | genetic immunisation with cDNA encoding human EphA2 |
| Format | Purified |
| Isotype | IgG1 (Matching secondary antibodies) |
| Clone | Kalpha-5H5 |
| Description | EphA2 (Eph receptor tyrosine kinase A2) belongs to the Eph tyrosine receptor familiy, the largest receptor tyrosine kinase family of transmembrane proteins. It encodes a 130 kDA transmembrane protein which is primarily found in adult human epithelial cells (1). Eph receptors and their ephrin ligands are important mediators of cell-cell communication and play roles in embryonic patterning, neuronal targeting, and vascular development during normal embryogenesis (2,3). The Eph family of receptor tyrosine kinases is frequently overexpressed in a wide variety of cancers and tumor cell lines. In particular, EphA2 is overexpressed in prostate, lung and colon cancers and 40% of breast cancers and it represent an attractive potential target for drug design (3,4). |
| Specificity | Anti-human EphA2 |
Application Details
| Application Notes | FACS: 1.2ug/10^6 cells, Cell-ELISA: 1:200 to 1:400, Immunofluorescence: 1 ug/10^6 cells |
| Concentration | 2 mg/ml |
| Purification | Protein G |
| Buffer | phosphate buffered saline, pH 7.2 |
| Storage | Short term: 2°C - 8°C. long term: -20°C (avoid repeated freezing and thawing) |
| Restrictions | For Research Use only |
Images
Publications
| Publications |
Lindberg, Hunter: "cDNA cloning and characterization of eck, an epithelial cell receptor protein-tyrosine kinase in the eph/elk family of protein kinases." in: Molecular and cellular biology, Vol. 10, Issue 12, pp. 6316-24, 1991 (PubMed).
Nakamoto, Bergemann: "Diverse roles for the Eph family of receptor tyrosine kinases in carcinogenesis." in: Microscopy research and technique, Vol. 59, Issue 1, pp. 58-67, 2002 (PubMed). Brantley-Sieders, Schmidt, Parker et al.: "Eph receptor tyrosine kinases in tumor and tumor microenvironment." in: Current pharmaceutical design, Vol. 10, Issue 27, pp. 3431-42, 2004 (PubMed). Ireton, Chen: "EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics." in: Current cancer drug targets, Vol. 5, Issue 3, pp. 149-57, 2005 (PubMed). |




